Codi QR

The Role of Bosutinib in Chronic Myeloid Leukemia: An Indian Perspective

Management of chronic myeloid leukemia (CML) has been transformed by the use of tyrosine kinase inhibitors (TKIs). Presently in India, five TKIs are approved for the management of CML with distinct safety profiles. The selection of TKIs for chronic phase (CP)-CML patients is based on treatment goals...

Descripció completa

Guardat en:
Autors principals: Mohan Bajranglal Agarwal, Manthanathu Joseph John, Punit Jain, Ashok Kumar Vaid, Ajay Bapna, Maheboob Basade, Palanki Satya Dattatreya, Anupam Chakrapani, Vijay Ramanan, R. Varadarajan, Murali Subramanian, Chirag Aniruddha Shah, Narayanakutty Warrier, Subhaprakash Sanyal, Tyavanagi Shankarmurthy Ashwin, Nagendra Ramanjinappa
Format: Artigo
Idioma:Inglês
Publicat: Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-08-01
Col·lecció:Indian Journal of Medical and Paediatric Oncology
Matèries:
chronic myeloid leukemia
India
bosutinib
tyrosine kinase inhibitors
chronic phase
Accés en línia:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1756477
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars